首页> 美国卫生研究院文献>Oncology Letters >MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells
【2h】

MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells

机译:MicroRNA-524-5p抑制胃癌细胞的生长和侵袭能力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous studies have demonstrated that microRNAs (miRNAs) are associated with tumor development and progression. miRNA-524-5p (miR-524-5p) has been reported to be involved in the development and progression of several types of cancer, but its role in gastric cancer has not been fully elucidated to date. Therefore, the aim of the present study was to investigate the expression levels and function of miR-524-5p in human gastric cancer. The expression levels of miR-524-5p were assessed in gastric cancer specimens and cell lines, including MKN-45, SGC-7901 and MGC-803 cell lines and gastric epithelial mucosa GES-1 cells, using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Cell proliferation and cell apoptosis assays and invasion analysis in gastric cancer cell lines were performed to evaluate the effects of miR-524-5p on gastric cancer cells in vitro. The expression levels of matrix metallopeptidase (MMP)-2 and MMP-9 were determined by RT-qPCR and western blot analysis. The expression of miR-524-5p was significantly decreased in gastric cancer tissues and cell lines. Additionally, the results of the in vitro experiments demonstrated that overexpression of miR-524-5p inhibited cell proliferation and invasion, and promoted cell apoptosis in gastric cancer cells. Human gastric cancer SGC-7901 and MGC-803 cell lines transfected with miR-524-5p exhibited reduced expression levels of MMP-2 and MMP-9. Taken together, the results of the present study indicated that miR-524-5p may function as a novel tumor suppressor gene in gastric cancer, and may serve as a biomarker and therapeutic target for the treatment of gastric cancer.
机译:先前的研究表明,microRNA(miRNA)与肿瘤的发生和发展有关。据报道,miRNA-524-5p(miR-524-5p)与几种类型的癌症的发生和发展有关,但迄今为止,尚未完全阐明其在胃癌中的作用。因此,本研究的目的是研究miR-524-5p在人胃癌中的表达水平和功能。使用逆转录定量聚合酶链反应评估miR-524-5p在胃癌标本和细胞系中的表达水平,包括MKN-45,SGC-7901和MGC-803细胞系以及胃上皮粘膜GES-1细胞(RT-qPCR)。进行胃癌细胞系的细胞增殖和细胞凋亡测定以及侵袭分析,以评估miR-524-5p对胃癌细胞的体外作用。通过RT-qPCR和western blot分析确定基质金属肽酶(MMP)-2和MMP-9的表达水平。在胃癌组织和细胞系中,miR-524-5p的表达明显降低。另外,体外实验的结果表明,miR-524-5p的过表达抑制胃癌细胞的细胞增殖和侵袭,并促进细胞凋亡。用miR-524-5p转染的人胃癌SGC-7901和MGC-803细胞系的MMP-2和MMP-9表达水平降低。两者合计,本研究的结果表明,miR-524-5p可能在胃癌中起新的抑癌基因的作用,并且可以作为治疗胃癌的生物标志物和治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号